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Abstract. 
 
We describe a novel mammalian protein ki-
nase related to two newly identified yeast and fly ki-
nases—Ipl1 and aurora, respectively—mutations in 
which cause disruption of chromosome segregation. We 
have designated this kinase as Ipl1- and aurora-related 
 
kinase
 
 
 
1 (IAK1)
 
.
 
 IAK1 expression in mouse fibroblasts 
is tightly regulated temporally and spatially during the 
 
cell cycle. Transcripts first appear at G
 
1
 
/S boundary, are 
elevated at M-phase, and disappear rapidly after com-
pletion of mitosis. The protein levels and kinase activity 
of IAK1 are also cell cycle regulated with a peak at 
M-phase. IAK1 protein has a distinct subcellular and 
temporal pattern of localization. It is first identified on 
the centrosomes immediately after the duplicated cen-
trosomes have separated. The protein remains on the 
centrosome and the centrosome-proximal part of the 
spindle throughout mitosis and is detected weakly on 
midbody microtubules at telophase and cytokinesis. In 
cells recovering from nocodazole treatment and in 
taxol-treated mitotic cells, IAK1 is associated with mi-
crotubule organizing centers. A wild-type and a mutant 
form of IAK1 cause mitotic spindle defects and lethal-
ity in 
 
ipl1
 
 mutant yeast cells but not in wild-type cells, 
suggesting that IAK1 interferes with Ipl1p function in 
yeast. Taken together, these data strongly suggest that 
IAK1 may have an important role in centrosome and/
or spindle function during chromosome segregation in 
mammalian cells. We suggest that IAK1 is a new mem-
ber of an emerging subfamily of the serine/threonine 
kinase superfamily. The members of this subfamily may 
be important regulators of chromosome segregation.
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I
 
ntricate
 
 controls have evolved to regulate the process
of cell division to ensure the creation of two daughter
cells with identical DNA contents. Once the cell has
duplicated its DNA, it must physically separate the chro-
mosome pair into opposite poles of the cells and then un-
dergo cytokinesis. Failure to faithfully segregate chromo-
somes equally into the daughter cells can result in aneuploidy
and may often lead to cell death. Such failure can also
have a profound impact on the fate of the daughter cells.
In multicellular organisms, aneuploidy has been associated
with tumorigenesis, as well as having drastic effects on de-
velopment.
Ordered chromosome segregation requires the regu-
lated interaction of many cellular components, including
the centrosome, the chromosomes, the kinetochores, mi-
crotubule arrays, and probably other less-understood cel-
lular components. Before chromosome segregation, in early
pro-metaphase, the centrosome duplicates and begins nu-
cleation of a radial array of microtubules, termed asters.
The duplicated centrosomes migrate around the nucleus
to establish the spindle poles. These then act as the micro-
tubule organizing centers (MTOCs)
 
1
 
 for the developing
mitotic spindle. Studies carried out in a variety of different
organisms have identified some of the estimated 150–200
proteins that make up the centrosome and mitotic spindle,
and some of these proteins have been found to be evolu-
tionarily conserved (Kalt and Schliwa, 1993). Gradually,
the functions of some of these components are being eluci-
dated.
Increasing evidence suggests that key functions of the
centrosomes and spindle may be regulated by reversible
phosphorylation (Verde et al., 1990). Early evidence for
this idea came from the generation of monoclonal anti-
bodies that recognized phosphorylated epitopes present in
the centrosome, kinetochores, and midbody of dividing
cells (Vandre et al., 1984, 1986). Subsequently, a number
of kinases have been identified that become localized to
 
1.
 
 Abbreviations used in this paper
 
: GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; IAK1, Ipl1- and aurora-related kinase 1; MBP, myelin
basic protein; MPF, M-phase promoting factor; MTOC, microtubule or-
ganizing center; PKA, protein kinase A; Plk1, Polo-like kinase; ts, tem-
perature-sensitive; T/STK, testis-derived serine/threonine kinases.
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the centrosome and spindle during mitosis (see below).
Entry into and exit from mitosis is regulated by a complex
formed by association of a regulatory subunit, cyclin B,
and a cyclin-dependent kinase, p34
 
cdc2
 
. This complex,
termed M-phase promoting factor (MPF), is an active
histone H1 kinase, and its activity regulates entry into
M-phase, while MPF inactivation, brought about by cyclin
destruction through the ubiquitin pathway, is required for
exit from M-phase. Interestingly, a fraction of the cellular
p34
 
cdc2
 
 pool is associated with the centrosomes, suggesting
that MPF may phosphorylate centrosomal proteins (Bailly
et al., 1989). Indeed, it has recently been demonstrated
that phosphorylation by p34
 
cdc2
 
 of a human kinesin-related
microtubule motor protein, Eg5, regulates its association
with the mitotic spindle (Blangy et al., 1995). A number of
other kinases, including casein kinase I (Brockman et al.,
1992), casein kinase II (Krek et al., 1992), Ca
 
2
 
1
 
/calmodu-
lin-dependent protein kinase II (Ohta et al., 1990), polo-
like kinase-1 (Golsteyn et al., 1995), and the cAMP-depen-
dent protein kinase II (Browne et al., 1980; Nigg et al.,
1985), have also been localized to the centrosome or spin-
dle, although none of them are exclusively localized to these
structures. Although these kinases have been localized
biochemically or immunologically to the centrosome or
mitotic spindle, the functional roles they play remain un-
clear. On the other hand, genetic analysis has unveiled a
number of components whose activity is required for proper
centrosome and mitotic spindle function and for ordered
chromosome segregation. For example, two related ki-
nases, Ipl1 and aurora, have recently been isolated from
budding yeast and flies, respectively, and mutational inac-
tivation of these kinases causes chromosome missegrega-
tion and disruption of centrosome (or spindle pole body)
separation (Francisco et al., 1994; Glover et al., 1995). De-
spite the fact that the subcellular localization of these ki-
nases has not been reported, this information unequivo-
cally demonstrates the importance of these genes in
regulating centrosomal and microtubule functions leading
to ordered chromosome segregation and cell division.
Many of the components of the cell cycle machinery are
evolutionarily conserved. For example, p34
 
cdc2
 
, originally
identified in 
 
Schizosaccharomyces pombe
 
, has been identi-
fied in all eukaryotes so far characterized. Similarly, the
dual specificity phosphatase, cdc25, which was also origi-
nally identified in 
 
S. pombe
 
 and is a key regulator of MPF
activity, is also widely conserved. Multiple members of this
family have been identified in flies, mice, rats, and humans
and have been found to regulate both the G
 
1
 
/S and G
 
2
 
/M
transitions (Millar and Russell, 1992; Jinno et al., 1994). It
seems likely, therefore, that genes identified as regulators
of centrosome and spindle function and of chromosome
segregation in lower eukaryotes may have mammalian
counterparts. In this paper, we describe the identification
and characterization of a novel mammalian kinase, Ipl1-
and aurora-related kinase 1 (IAK1), related to yeast and
fly proteins recognized as chromosome segregation regu-
lators. Expression of IAK1 is tightly regulated during the
cell cycle; IAK1 transcripts first appear in S-phase, are ele-
vated at M-phase, and disappear rapidly after completion
of mitosis. Western blot analysis reveals that the IAK1
protein is first detected in S-phase, peaks at M-phase, and
rapidly disappears at the completion of mitosis.
 
IAK1 protein is first identified immunocytochemically
on the centrosomes just after centrosome duplication. It
remains on the centrosome throughout division and is also
localized to spindle microtubules from metaphase on-
wards. Unlike other kinases, which associate with the cen-
trosome and spindle during mitosis, IAK1 associates uniquely
with these structures and is undetectable immunocy-
tochemically on other structures in mitotic cells or in inter-
phase cells. We also present data demonstrating that IAK1
can interact with components of the yeast chromosome
segregation pathway. Taken together, these data strongly
suggest that IAK1 is likely to have an important function
during centrosome duplication, spindle organization, and
chromosome segregation in mammalian cells. We further
suggest that IAK1 may be a member of an emerging sub-
family of the serine/threonine kinase superfamily.
 
Materials and Methods
 
DNA Amplification and Cloning
 
1 
 
m
 
g of total RNA extracted from adult mouse testes was reverse tran-
scribed with an oligo dT-adaptor primer 5
 
9
 
 AATTCTGCAGTGAT-
ATC(T)
 
17
 
 3
 
9
 
 using muMLV reverse transcriptase (GIBCO BRL, Gaith-
ersburg, MD). The cDNA was used in a subsequent 3
 
9
 
 rapid amplification
of cDNA ends (RACE) with the same oligo dT-adaptor primer and a
serine/threonine kinase domain-specific degenerate primer 5
 
9
 
 GCGCA-
TCC (C/A) GI GA(C/T) (C/T)TI AA(A/G) CCI (C/G)AI AA 3
 
9
 
 (where
I denotes inosine) derived from the conserved RDLKPEN domain
(Hanks et al., 1988). The PCR parameters were 94
 
8
 
C for 1 min, 50
 
8
 
C for 1
min, and 72
 
8
 
C for 10 min, repeated for 35 cycles. The PCR products were
treated with T4 DNA polymerase in the presence of dGTP and dCTP to
create an EcoRI overhang on one end and a blunt end on the other
(Stoker, 1990), and the PCR fragments were cloned into EcoRI-SmaI
double-digested pBluescript KS
 
1
 
 (Stratagene, La Jolla, CA). A degener-
ate 20 mer 5
 
9
 
 CTI GCI GA(T/C) TTT GGI (T/C)TI 3
 
9 
 
corresponding to
the amino acids LADFGLA was labeled with [
 
g
 
-
 
32
 
P]ATP (Amersham
Corp., Arlington Heights, IL) and polynucleotide kinase (Boehringer
Mannheim Corp., Indianapolis, IN) and used to screen the PCR library.
Hybridization was carried out in 6
 
3
 
 SSC, 5% Denhardt’s, 0.1% SDS, and
100 
 
m
 
g/ml Salmon sperm DNA overnight at 37
 
8
 
C. The filters were washed
in 2
 
3
 
 SSC and 0.1% SDS twice at room temperature and finally at 37
 
8
 
C
for 10 min each. The clones designated testis-derived serine/threonine ki-
nases (T/STKs), which hybridized to this primer, were analyzed further by
sequencing.
 
cDNA Cloning and Sequencing
 
Duplicate filters containing 
 
z
 
500,000 recombinants from an adult mouse
testis library (5
 
9
 
 stretch cDNA library in 
 
l
 
gt 11; Clontech Labs, Palo Alto,
CA) were screened with an 850-bp EcoRI fragment derived from the PCR
clone designated T/STK 5. The fragment was labeled with [
 
a
 
32
 
P]dCTP
(Amersham Corp.) using a random prime labeling kit (Boehringer Mann-
heim Corp.) to a specific activity of 3 
 
3
 
 10
 
9 
 
cpm/
 
m
 
g. Hybridization was
carried out overnight at 65
 
8
 
C in 5
 
3
 
 SSPE, 5% Denhardt’s, 0.1% SDS, and
100 
 
m
 
g/ml of Salmon sperm DNA. The hybridized filters were washed
twice with 2
 
3
 
 SSC and 0.1% SDS at room temperature followed by a
stringent wash at 65
 
8
 
C with 0.2% SSC and 0.1% SDS. Plaques giving sig-
nals in duplicate filters were further purified by hybridization. cDNA in-
serts were subcloned into pBluescript KS
 
1
 
 as EcoRI fragments. Sequenc-
ing of plasmids containing inserts was carried out in both directions using
the T3 and T7 primers (Stratagene) and subsequently by primer walking
using other internal primers designed from the sequenced region. The 5
 
9
 
UTR sequence of IAK1 was isolated by the 5
 
9
 
 RACE using adult mouse
testes marathon ready cDNA (Clontech Labs) according to the manufac-
turer’s protocol. The sequence of the first strand primer and the nested
primer are 5
 
9
 
 CCA GCT GTG TTT TAA ACA GCA CCT TCA 3
 
9
 
 (nu-
cleotides 582–609) and 5
 
9
 
 ATG TCA CCC CGA CGC CAC ACA GC 3
 
9
 
(nucleotides 108–130), respectively. All the recombinant DNA techniques
described above were essentially from Sambrook et al. (1989). Sequencing 
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was carried out using Sequenase version 2 kit (United States Biochemical
Corp., Cleveland, OH) according to the manufacturer’s protocol.
 
RNA Isolation and Northern Analysis
 
Total RNA from adult tissues was isolated essentially as described by
Chomczynski and Sacchi (1987). For Northern analysis, 30 
 
m
 
g of total
RNA was separated on a 1.5% agarose-formaldehyde gel, transferred to
Nytran filters (Schleicher and Schuell, Inc., Keene, NH), and baked. Blots
were hybridized according to Church and Gilbert (1984) with the 850-bp
EcoRI fragment derived from IAK1 PCR clone labeled using a random
prime labeling kit. This probe does not cross-react with the related kinase
expressed in germ cells since the transcript sizes are distinct, and more-
over, the probes for each gene map to distinct locations in the mouse ge-
nome. Blots were stripped and reprobed with either mouse 
 
b
 
-actin or
mouse glyceraldehyde 3-phosphate dehydrogenase (GAPDH) to quanti-
tate RNA loading.
 
Bacterial Expression and Purification of 
Recombinant IAK1
 
Recombinant wild-type IAK1 protein was expressed in 
 
Escherichia coli
 
under the control of the inducible T7 promoter. The expression vector
pRSET C (Invitrogen, San Diego, CA) was used to synthesize a histidine-
tagged IAK1 protein fused in frame with gene 10 of phage T7. When
cloned at the EcoRI site of pRSET C, the recombinant protein is 5 kD
larger due to the NH
 
2
 
-terminal fusion.
Because of the presence of an internal EcoRI site in the IAK1 coding
region, to make a wild-type construct, a three-piece ligation containing
EcoRI-HindIII–digested pRSET C, EcoRI-SphI fragment containing the
5
 
9
 
 end of IAK1 cDNA, and SphI-HindIII fragment containing the remain-
ing 3
 
9
 
 end of IAK1 cDNA was carried out. This construct, designated
pRSET C/W, comprises the entire IAK1 coding region and 250 bp of 3
 
9
 
 UTR.
 
Construction of IAK1 Mutants
 
Mutation in the metal binding site of serine/threonine kinases typically
abolishes the kinase activity (Gibbs and Zoller, 1991). To construct re-
combinant plasmids expressing a mutant IAK1 protein containing a
D287N mutation, a primer, 5
 
9
 
 GGAGCATGCACCACCCGAAGTTTG
3
 
9
 
, incorporating the necessary nucleotide change was used in combina-
tion with 5
 
9
 
 vector-specific primer for PCR on the pRSET C/W template.
The 860-bp PCR product was digested with EcoRI and SphI, and a three-
piece ligation containing EcoRI-HindIII–digested pRSET C, the mutated
EcoRI-SphI PCR–derived fragment, and 3
 
9
 
 SphI-HindIII fragment of the
IAK1 cDNA was carried out. This construct was designated pRSET C/D.
The constructs IAK1
 
WT
 
 (wild-type) and IAK1
 
D287N
 
 (D287N mutant)
expressing wild-type and mutant recombinant IAK1 under 
 
GAL10
 
 pro-
moter were made as follows: Wild-type and mutant IAK1 cDNAs were
derived from PRSET C/W and pRSET C/D, respectively (see above), as
XhoI-HindIII fragments and were used to replace the SEP1 gene (XhoI-
HindIII fragment) in pRDK249 (Johnson and Kolodner, 1991).
For routine propagation, all the recombinant plasmids were trans-
formed into 
 
E. coli
 
 DH5
 
a
 
. For bacterial expression of the recombinant
proteins, the plasmids were transformed into 
 
E. coli
 
 BL 21(DE3) pLysS
(Novagen, Inc., Madison, WI). In all cases, the synthesis of fusion proteins
was induced with 1 mM IPTG.
To purify the bacterially expressed fusion proteins, the induced cells
were lysed in a buffer containing 10 mM Tris-HCl, pH 8, 300 mM NaCl,
and 0.1% Triton X-100. The lysate was centrifuged, and the supernatant
was mixed with Ni-NTA agarose (Qiagen, Chatsworth, CA) and incu-
bated with shaking at 4
 
8
 
C for 2 h. The agarose beads were washed several
times with a wash buffer (10 mM Tris-HCl, pH 8, 300 mM NaCl, and 20
mM imidazole) to remove unbound proteins. The bound recombinant
protein was eluted from the beads with 10 mM Tris-HCl, pH 8, containing
200 mM imidazole.
In vitro translation reactions were carried out with IAK1 cDNA cloned
at the EcoRV site pCDNA3 (Invitrogen) using the TNT T7 Quick Cou-
pled Transcription/Translation System (Promega Corp., Madison, WI) ac-
cording to manufacturer’s specifications. Plasmid containing luciferase
gene is used for control translation.
 
Cell Culture and Synchronization
 
NIH 3T3 cells were obtained from the American Type Culture Collection
(Rockville, MD) and routinely cultured in DME supplemented with 10%
BCS in a humidified 5% CO
 
2
 
 atmosphere at 37
 
8
 
C. Mitotic cells were ob-
tained as described in Lake and Jelinek (1993), with minor modifications.
Cells were growth arrested in 0.5% serum–supplemented medium for 48 h.
After resuming growth in medium containing 10% serum for 12 h, no-
codazole (0.4 
 
m
 
g/ml) was added to arrest the cells at metaphase. After 18 h,
mitotic cells were collected by mechanical shake off, washed three times in
serum-free medium, and replated in DME with 10% BCS without no-
codazole. Cells were also blocked at the G
 
1
 
/S phase boundary with aphidi-
colin. Briefly, cells were growth arrested as described above and released
from growth arrest into medium containing aphidicolin (5 
 
m
 
g/ml) for 16 h.
These cells were then washed three times with medium without aphidi-
colin, fed with fresh medium, and allowed to resume cell cycle progres-
sion. Samples were collected at hourly intervals after release from aphidi-
colin block. The synchrony of cells was monitored by the analysis of their
DNA content at different time points after release from nocodazole or
aphidicolin blocks by staining with propidium iodide and by flow cytometry.
 
Microtubule Disassembly/Reassembly and Stabilization 
In Vivo
 
NIH 3T3 cells were grown on fibronectin-coated coverslips to 80% conflu-
ency and were treated with 1–10 
 
m
 
g/ml nocodazole (Sigma Chemical Co.,
St. Louis, MO) for 4 h. The drug was removed by washing the cells twice
in drug-free medium, and the cells were fixed for immunostaining at timed
intervals after release from nocodazole block. For taxol treatment, cells
were grown as described above and then incubated with 10 
 
m
 
M taxol for 5 h
before fixation.
 
Antibodies
 
An anti-IAK1 antiserum was made by immunizing rabbits with a synthetic
peptide (CGHTSKEPTSKSS) corresponding to the 12 COOH-terminal
amino acids of the IAK1 protein that was linked to KLH. This peptide se-
quence is distinct from that of the other kinases in this family, including
STK1 (Niwa et. al., 1996) and the germ cell-specific kinase we have identi-
fied (our own unpublished data). Rabbits were immunized with peptide–
protein conjugate. Another IAK1 rabbit antiserum was generated against
the histidine-tagged full-length recombinant protein produced in 
 
E. coli
 
and gave results identical to those obtained with the COOH-terminal pep-
tide antiserum.
 
In Vitro Kinase Assay
 
NIH 3T3 cells from different stages in the cell cycle were lysed in lysis
buffer consisting of PBS containing 1% NP-40, 1% BSA, 25 mM sodium
fluoride, and a cocktail of protease inhibitors (Boehringer Mannheim
Corp.), and the lysate was centrifuged at 12,000 rpm for 10 min at 4
 
8
 
C. The
supernatants were precleared at 4
 
8
 
C for 1 h with normal rabbit serum, and
then the IAK1 specific antiserum was added at 1:500 dilution and incu-
bated at 4
 
8
 
C with shaking for 2 h. The immunoprecipitates were collected
by incubation with protein A–Sepharose for 1 h and the beads were
washed three times with lysis buffer, three times in lysis buffer without
BSA, and three times with kinase buffer (20 mM Tris, pH 7.4, 10 mM
MgCl
 
2
 
, and 25 mM 
 
b
 
-glycerophosphate). 25 
 
m
 
l of kinase buffer containing
2 
 
m
 
g of myelin basic protein and 20 
 
m
 
Ci (3,000 Ci/mmol) of [
 
g
 
-
 
32
 
P]ATP
was added to the beads and the kinase assay was carried out at 30
 
8
 
C for 20
min. An equal volume of SDS containing sample buffer was added, and
the samples were boiled for 5 min and separated on a 12% SDS–polyacryl-
amide gel. The incorporation of [
 
g
 
-
 
32
 
P]ATP into myelin basic protein was
analyzed by both gel analysis and autoradiography, as well as scanning
with a Molecular Dynamics phosphoimager (Sunnyvale, CA).
In experiments to assess the kinase activity of the wild-type and D287N
mutant version of IAK1, flag-tagged wild-type and mutant versions of the
IAK1 were transiently expressed in NIH 3T3 cells under the control of the
cytomegalovirus promoter. Around 24 h after transfection, cells were
treated with nocodazole (0.2 
 
m
 
g/ml), and cells were collected 48 h after
transfection. The flag-tagged proteins were captured on anti–flag M2 af-
finity gel (Kodak, Rochester, NY) and used for kinase assays as described
before. The activity of the wild-type and D287N mutant was compared to
that of the control mock-transfected cells treated in the same manner.
 
Western Blot Analysis
 
Affinity-purified recombinant bacterial proteins and lysates from nocoda- 
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zole- blocked NIH 3T3 cells were separated on 10% SDS-PAGE and blot-
ted onto nitrocellulose. After 1 h of blocking in 5% nonfat dry milk, the
blot was incubated overnight at 4
 
8
 
C with preimmune (1:2,000) or the
COOH-terminal peptide antibody (1:2,000). Unbound primary antibodies
were removed by several washes in PBS containing 0.5% Tween-20. Incu-
bation with secondary peroxidase-coupled goat anti–rabbit IgG (Boehr-
inger Mannheim Corp.) was carried out for 1 h at room temperature.
After several washes with PBS containing 0.5% Tween-20, the secondary
antibody was detected using the enhanced chemiluminescence detection
system (Amersham Corp.) according to the manufacturer’s protocol.
 
Immunocytochemistry
 
For immunocytochemical staining, dividing NIH 3T3 cells were grown on
glass coverslips in wells of a 24-well plate. The cells were fixed in metha-
nol (
 
2
 
20
 
8
 
C) for 10 min at room temperature. After fixation, the cells were
washed three times in PBS and then incubated in blocking buffer (10%
heat-inactivated, normal goat serum, 4% BSA Fraction V in PBS) for 10
min at room temperature. Incubation with the primary antibody diluted in
blocking buffer was carried out for 1 h at room temperature, and the cov-
erslips were then washed three times in PBS. The cells were then incu-
bated with a rhodamine-conjugated, goat anti–rabbit antibody (Boehringer
Mannheim Corp.) for 1 h at room temperature, washed three times in
PBS, and mounted on slides. The slides were observed on a microscope
(model Microphot FXA; Nikon, Inc., Melville, NY) equipped with epiflu-
orescence optics. When cells were double stained for microtubules using a
mouse monoclonal anti–
 
b
 
-tubulin antibody (Sigma Chemical Co.), the
cells were incubated simultaneously with both primary antibodies, washed,
and then incubated simultaneously with the goat anti–rabbit antiserum
(see above) and FITC-conjugated goat anti–mouse antiserum (Sigma
Chemical Co.). Preliminary experiments showed that neither the primary
nor secondary antibodies cross-reacted or inhibited the binding of the
other antibody. Labeled cells were examined using a confocal laser scan-
ning microscope (Carl Zeiss, Inc., Oberkochen, Germany) essentially as
described by Tsfarty et al. (1992). The instrument was calibrated with flu-
orescent beads to ensure that the filters excluded other wavelengths. Im-
ages were captured under fixed parameters using a 40
 
3
 
 objective. For im-
munocytochemical staining of yeast cells, formaldehyde-fixed yeast cells
were treated with zymolyase and then processed for fluorescent staining
of microtubules and DNA as previously described (Pringle et al., 1989).
 
Yeast Strains, Media, and Genetic Techniques
 
The yeast strains used are CCY98-3D-1 (
 
a
 
 hom3 his3-
 
D
 
200 ura3-52 lys2-
 
D
 
101::HIS3::lys2-
 
D
 
102
 
) and CCY98-3D-1-1 (
 
a 
 
hom3 his3-
 
D
 
200 ura3-52
lys2-
 
D
 
101::HIS3::lys2-
 
D
 
102 ipl-14
 
), which was derived from CCY98-3D-1
by a two-step gene replacement procedure (Francisco et al., 1994). There-
fore, these two strains are absolutely isogenic.
Synthetic minimal medium (SD) supplemented with casamino acids
and adenine and with glucose, raffinose, or galactose as sole carbon source
was prepared as described elsewhere (Rose et al., 1990).
 
Results
 
Molecular Cloning of IAK1
 
In an attempt to clone novel serine/threonine kinases, a 3
 
9
 
RACE reaction was performed on adult mouse testis total
RNA using a degenerate primer whose design was based
on the conserved amino acid residues in the catalytic do-
main of serine/threonine kinases (Hanks et al., 1988). The
RACE products were cloned into pBluescript and were
further selected by hybridization to another kinase do-
main–specific oligonucleotide (see Materials and Meth-
ods). Positive clones were analyzed by sequencing and fur-
ther characterized by comparison with other kinases in the
database (GenBank) using TFASTA (Pearson and Lip-
man, 1988) and BLAST (Altschul et al., 1990) programs.
One of the clones (designated T/STK 5) was unique and
novel. It encodes the protein we have named IAK1. To
isolate a full-length cDNA for IAK1, an 850-bp EcoRI
fragment of the PCR clone was used to screen a testis
cDNA library in 
 
l
 
gt11. 15 positive clones were identified,
and sequence analysis revealed that they all represent por-
tions of the same cDNA. The longest cDNA isolated from
this screening had the complete coding region. To isolate
more 5
 
9
 
 sequence (5
 
9 UTR), a 59 RACE was performed. A
composite sequence from the longest cDNA clone and the
59 RACE clone is presented in Fig. 1. The predicted IAK1
polypeptide has 417 amino acid residues with a calculated
molecular mass of 46 kD. The putative catalytic kinase do-
main lies towards the COOH-terminal portion of the pro-
tein and contains all the residues critical for protein kinase
function. The protein lacks a signal peptide and a putative
transmembrane domain, suggesting that it is likely to be
not secreted or membrane associated. At the NH2-termi-
nus of the kinase domain lies the consensus motif Gly-
X-Gly-XX-Gly, which constitutes part of the ATP-binding
site. The residues in the subdomain VI, Arg-Asp-Leu-Lys-
Pro-Glu-Asn, and subdomain VIII, Gly-Thr-Leu-Asp-
Tyr-Leu-Pro-Pro-Glu, strongly suggest that IAK1 is a
bona fide serine/threonine kinase (Hanks et al., 1988).
IAK1 protein contains two sequences that match the pro-
Figure 1. Nucleotide and deduced amino acid sequences of
mouse IAK1 cDNA. The composite nucleotide sequence of
cDNA clone and the RACE clone is shown. Sequence informa-
tion is derived from the RACE clone spanning the first 130 bp
and the cDNA clone spanning 62–1,503 bp. The in-frame stop
codon is doubly underlined. The deduced amino acid sequence of
IAK1 kinase is also shown. The putative catalytic domain is dis-
played in bold face. The PKA consensus phosphorylation sites
are underlined.Gopalan et al. A Novel Mammalian, Mitotic Spindle–associated Kinase 647
tein kinase A (PKA) consensus phosphorylation site R/K-
R/K-X-S/T (Pearson and Kemp, 1991). These sites are po-
sitioned close to each other and are located in the kinase
domain (Fig. 1). One of these PKA sites is in the catalytic
domain activation loop and is therefore unlikely to be
phosphorylated by PKA.
IAK1 Encodes a Protein Similar to Ipl1 and
Aurora Kinases
Southern blot analysis of genomic DNA isolated from a
variety of organisms indicates that IAK1 is highly evolu-
tionarily conserved. We were able to detect hybridization
of the IAK1 cDNA to genomic DNA isolated from hu-
man, chicken, Xenopus, and budding yeast (data not
shown). Comparison of IAK1 sequence to other kinases in
the database revealed that IAK1 is related to PKA and
protein kinase C families. However, IAK1 is more closely
related to Ipl1 and aurora, and they form a distinct sub-
family of the serine/threonine kinases. The Ipl1 gene was
originally isolated in studies designed to identify genes in-
volved in chromosome disjunction in Saccharomyces cere-
visiae (Chan and Botstein, 1993). Temperature-sensitive
(ts) ipl1 mutant cells missegregate chromosomes severely
and die at elevated temperatures. Subsequent isolation
and characterization of the Ipl1 gene revealed that Ipl1 en-
codes a putative serine/threonine kinase and, furthermore,
that abolition of Ipl1 gene function results in severe non-
disjunction (Francisco et al., 1994). aurora was isolated in
a search for mutations that affect the centrosome cycle in
Drosophila. The loss of function of the kinase encoded by
aurora results in failure of centrosome separation leading
to the formation of monopolar spindles (Glover et al.,
1995). Fig. 2 shows a comparison of the amino acid se-
quence between IAK1, Ipl1p, and aurora and two other
related kinases. The sequence homology between these ki-
nases extends beyond the highly conserved COOH-termi-
nal catalytic domain. Ipl1p shows an overall identity of
47% over the entire protein and 49% identity in the kinase
domain to IAK1. Similarly, aurora is 56% identical to
IAK1 over the entire protein and 58% identical in the ki-
nase domain. IAK1 also shows a high degree of homology
(74%) to a newly described cell cycle–regulated kinase of
unknown function, STK1, identified from mouse testis
(Niwa et al., 1996). It also shares 75% homology with Eg2,
a frog homologue also of unknown function, whose se-
quence data are available from GenBank/EMBL/DDBJ
under accession number Z17207 (Fig. 2).
Figure 2. Amino acid sequence alignment of IAK1 with those of
the STK1, Eg2, Ipl1, and aurora kinases. Identical amino acids
are shaded. Where amino acids are conserved in three or more of
these related kinases, shading is in black. Where amino acids are
conserved in only two members, shading is in gray. To maximize
alignment, gaps represented by dots were introduced. Amino
acid alignments were carried out using the University of Wiscon-
sin Genetics Computer Group Program PILEUP.
Figure 3. Northern blot analysis of IAK1 mRNA expression in
adult mouse tissues. Total RNA (30 mg) from adult mouse tissues
was separated on a formaldehyde-agarose gel and blotted onto
nytran membranes. The blot was hybridized with an 850-bp frag-
ment derived from the PCR clone. The blot was stripped and re-
probed with GAPDH to quantitate RNA loading.The Journal of Cell Biology, Volume 138, 1997 648
IAK1 Is Highly Expressed in Testis and Ovary and Is 
Cell Cycle Regulated
Northern blot analysis of IAK1 expression in adult mouse
tissues was carried out using an 850-bp fragment compris-
ing the entire 39 UTR and part of the COOH-terminal
coding region as a probe. We identified transcripts of z2
kb in testis and ovary but not in the other adult tissues ex-
amined (Fig. 3). The multiple transcripts observed proba-
bly result from differential splicing or differential polyade-
nylation rather than identification of other members of
this family since the probe used shows less than 20% ho-
mology to other members of this gene family. IAK1 tran-
scripts were also detected in RNA from NIH 3T3 cells
(Fig. 3) as well as in CCE embryonic stem cells, F9 embry-
onal carcinoma cells, adult spleen, and thymus (data not
shown). These data suggest that IAK1 is expressed in most
dividing cells. The failure to detect IAK1 transcripts in
many adult tissues probably reflects the low level of cell di-
vision in many adult tissues. To further study whether the
expression of IAK1 is cell cycle regulated, we blocked
NIH 3T3 cells in M-phase with nocodazole and analyzed
IAK1 RNA expression after release from block and pro-
gression through the cell cycle. In nocodazole-treated
cells, high levels of IAK1 transcripts were observed. As
cells progressed into G1 phase of the cell cycle, transcript
levels declined and by 3 h after release from nocodazole
block, IAK1 transcripts were virtually undetectable. About
12 h after release from nocodazole block, cells entered
S-phase, and IAK1 transcripts again became detectable
(Fig. 4 A). Similar cell cycle–dependent accumulation of
transcripts was obtained by block and release experiments
using other blocking agents, such as aphidicolin. In aphidi-
colin block and release experiments, IAK1 transcripts were
present at the G1/S boundary (0 h), reached highest levels
around M-phase (7 h), and started to decline as cells en-
tered the next G1 phase (10 h) (Fig. 4 B). These data
strongly suggest that the accumulation of IAK1 transcripts
is regulated in a cell cycle–dependent manner.
IAK1 Protein Levels and Kinase Activity Are Cell 
Cycle Regulated
To study the expression pattern of the IAK1 protein and
its subcellular localization, we raised a polyclonal antise-
rum to the 12 COOH-terminal amino acids of the IAK1
protein. This peptide sequence is distinct from that of
other members of this family including STK1 and the germ
cell–specific kinase related to IAK1. In Western blot anal-
ysis of nocodazole-treated NIH 3T3 cells, this antiserum
recognized a major protein of z46 kD, as well as some ad-
ditional minor bands (Fig. 5 A, lane 3). Antiserum binding
to the 46-kD band (but not the other minor bands) was
completely competed with the immunogenic peptide (Fig.
5 A, lane 5). A recombinant, histidine-tagged IAK1 pro-
tein produced in bacteria was also recognized by this anti-
Figure 4. Cell cycle analysis of IAK1 expression by Northern blot analysis. (A) Nocodazole block and release: Cells were serum-starved
for 48 h in 0.5% b serum–containing medium. After resuming growth in a medium containing 10% serum for 12 h, cells were incubated
in a medium containing 0.4 mg/ml of nocodazole for 18 h. Mitotic cells were collected by mechanical shake-off, replated into medium
without nocodazole, and allowed to progress though the cell cycle. (B) Aphidicolin block and release: NIH 3T3 cells were serum-starved
for 48 h in medium supplemented with 0.5% serum. The starved cells were released into the medium containing 10% serum and 5 mg/ml
of aphidicolin for 18 h. After the aphidicolin block, the cells were washed three times in serum-free medium and released into medium
containing 10% serum without aphidicolin. Cells were collected at different times after the release, and total RNA was isolated. North-
ern blot analysis of total RNA isolated from aphidicolin- and nocodazole-blocked and released cells were performed as described above
except blots were reprobed with a b-actin probe to quantitate loading. The degree of synchrony of NIH 3T3 cells was determined by
propidium iodide staining and flow cytometry and is shown as the percentage of cells of G2/M phase.Gopalan et al. A Novel Mammalian, Mitotic Spindle–associated Kinase 649
judged by FACS® analysis. We also blocked cells at M-phase
with nocodazole and followed IAK1 protein levels after
release from the nocodazole block. Consistent with data
from the aphidicolin block and release experiments, we
detected high levels of IAK1 protein in M-phase cells. As
cells released from nocodazole block reentered and pro-
gressed through the cell cycle into the G1 phase, IAK1
protein levels rapidly declined. These data demonstrate
that IAK1 protein levels, like IAK1 transcripts, are regu-
lated in a cell cycle–dependent manner.
To find out whether IAK1 activity is also cell cycle regu-
lated, we measured the activity of IAK1 through the cell
cycle. Since our preliminary results did not show any indi-
cation of IAK1 autophosphorylation, we used exogenous
substrates such as histone H1, b-casein, and myelin basic
protein (MBP) for measuring IAK1 kinase activity. Fig. 6
B shows the MBP kinase activity of IAK1 measured in
cells released from aphidicolin and nocodazole block as
described above. The kinase activity pattern of IAK1 is also
cell cycle regulated with its maximum activity at M-phase.
The peak of kinase activity occurs 2–3 h after the protein is
first detected by Western blot analysis, suggesting that
posttranslational modifications may regulate IAK1 kinase
activity.
IAK1 Protein Is Localized to the Centrosome and 
Mitotic Spindle
To localize IAK1 protein in dividing NIH 3T3 cells, we
serum (Fig. 5 A, lane 4), and again the binding could be
completely competed out with the immunogenic peptide
(Fig. 5 A, lane 6). Antibody binding was not inhibited by
another, unrelated peptide, suggesting that peptide com-
petition was specific (Fig. 5 A, lanes 7 and 8). In vitro
translation of the full-length IAK1 cDNA in a reticulocyte
lysate resulted in two protein bands (Fig. 5 B, lane 2), in
which the faster migrating one is predicted to result from
the translational initiation from the downstream methio-
nine at position 23 of IAK1 protein. Interestingly, the en-
dogenous IAK1 protein (Fig. 5 B, lane 3) corresponds to
the faster migrating band, and we do not detect any endog-
enous protein corresponding to our full-length IAK1 cDNA.
This suggests that the cDNA we isolated could be a splice
variant of IAK1 and that the protein product corresponding
to this variant is less abundant or less stable in NIH 3T3
cells. Taken together, these data suggest that this antise-
rum specifically recognizes the IAK1 protein in NIH 3T3 cells.
Using this antiserum, we analyzed IAK1 protein levels
by Western blot analysis in cells at different stages of the
cell cycle (Fig. 6 A). In cells isolated 7 h after release from
serum-starvation (G1 phase), we were unable to detect
IAK1 protein, suggesting that the protein is not present
during this stage of the cell cycle. Cells were also blocked
with aphidicolin at the G1/S phase boundary, and after re-
lease of cells from this block, we gradually saw accumula-
tion of IAK1 protein. The peak of IAK1 expression oc-
curred z7 h after release from aphidicolin block, at which
time a large percentage of cells were in G2/M-phase as
Figure 5. (A) Characteriza-
tion of an IAK1-specific
COOH-terminal peptide an-
tiserum. A COOH-terminal
peptide antiserum was char-
acterized by Western blot
analysis against a bacterially
produced recombinant IAK1
protein (lanes B) and ex-
tracts of mitotic NIH 3T3
cells (lanes 3T3). For peptide
competition, the antiserum
was preincubated with 5 ml of
a 1 mg/ml solution of the
peptide immunogen or an
unrelated peptide for 1 h at
room temperature before in-
cubation with the blot. The
arrowhead indicates bacteri-
ally expressed recombinant
IAK1, and the arrow indi-
cates the endogenous IAK1
in NIH 3T3 cells. (B) In vitro
translation of IAK1. Full-
length IAK1 cDNA cloned
in pcDNA3 was used for in
vitro translation using the
TNT T7 Quick Coupled Tran-
scription/Translation system.
An aliquot of the translated
products was analyzed along
with cell extract from nocodazole-blocked cells on 10% polyacrylamide gel. A similar plasmid containing luciferase gene in the place of
IAK1 cDNA was used for the control. The gel was blotted and probed with IAK1-specific peptide antiserum as described in the Materi-
als and Methods section. Lane 1, Control luciferase cDNA translated in vitro; lane 2, IAK1 cDNA translated in vitro; lane 3, nocoda-
zole-treated NIH 3T3 cell lysate.The Journal of Cell Biology, Volume 138, 1997 650
carried out indirect immunocytochemistry (Fig. 7). The lo-
calization pattern of IAK1 protein was distinct. We were
unable to detect IAK1 protein in interphase cells (Fig. 7
A), and the protein was first detected in the separated, du-
plicated centrosomes of prophase cells (Fig. 7 B). The pro-
tein remained in the duplicated centrosomes during migra-
tion around the nucleus (Fig. 7 C) and at metaphase and
anaphase was found in the centrosome and on spindle mi-
crotubules (Fig. 7, D and E). The protein remains on the
centrosome and spindle throughout division. At telophase,
IAK1 is still associated with the centrosomes, and weak
staining was observed in the newly forming midbody mi-
crotubules. During cytokinesis, IAK1 remains associated
with the midbody microtubules (Fig. 7 F). Antibody bind-
ing could again be competed with immunogenic peptide
but not with an unrelated peptide, demonstrating that the
pattern described was caused by antibody binding to the
IAK1 protein (data not shown). Moreover, an identical
staining pattern was observed using a different polyclonal
antiserum raised against the whole IAK1 protein (data not
shown). Counterstaining of cells with a monoclonal anti-
body that recognizes microtubules demonstrated that the
antibody was indeed binding to the centrosomes and spin-
dle (Fig. 7). The IAK1 staining pattern was observed inde-
pendently of b-tubulin staining and was not the result of
the strong fluorescein signal bleeding through into the
rhodamine channel.
To further investigate the association of IAK1 protein
with centrosomes and spindle microtubules, we analyzed
IAK1 localization in cells treated with the microtubule-
destabilizing drug nocodazole. When log phase cultures of
NIH 3T3 cells are treated with nocodazole, cells arrest and
accumulate at metaphase. Nocodazole-arrested cells were
stained with a monoclonal anti–b-tubulin antibody and the
anti-IAK1 antiserum. In nocodazole-treated cells, b-tubu-
lin staining was observed throughout the cytoplasm, and
two weak foci were also observed. These foci are likely to
be the centrioles, which are known to be resistant to the
effects of nocodazole (De Brabander et al., 1980). Fig. 8 A
shows such a cell in which only one of these foci is in the
focal plane. IAK1 staining in these cells was also observed
weakly throughout the cytoplasm and in bright dots coin-
cident with the foci of b-tubulin staining (Fig. 8 A). These
data strongly suggest that most of the IAK1 protein in di-
viding cells is associated with pericentriolar material and
tubulin of the mitotic spindle, which is consistent with the
observed IAK1 staining pattern in dividing cells. They also
suggest that a pool of IAK1 is associated with the centri-
oles independently of microtubule polymerization. In cells
recovering from nocodazole block, microtubules reform
Figure 6. (A) Western blot analysis of IAK1 levels during the cell cycle. NIH 3T3 cells were blocked at various stages of the cell cycle by
serum starvation or treatment with aphidicolin or nocodazole. After release from block, cells were harvested at intervals to collect cells
at different stages of the cell cycle. Cell lysates prepared from 400,000 cells were then separated by SDS-PAGE and analyzed by West-
ern blot analysis with the IAK1 antiserum. Cells were harvested 7 h after release from serum starvation (G1), 0, 3, 5, 7, 8, 9, and 10 h af-
ter release from aphidicolin block (A0–A10), and 0, 15, 30, 60, and 120 min after release from nocodazole block (N0–N120). The per-
centage of cells at G2/M phase of the cell cycle, as judged by propidium iodide staining and FACS® analysis, is shown below each lane.
(B) Activity profile of IAK1 kinase through cell cycle. NIH 3T3 cells at different stages of the cell cycle were collected as described in
Fig. 5 C. Cells were lysed, and in vitro kinase activity of IAK1 was determined in cell lysates using myelin basic protein as the exogenous
substrate as detailed in Materials and Methods. The percentage of cells in G2/M phase was determined for each sample by flow cytome-
try and presented for comparison.Gopalan et al. A Novel Mammalian, Mitotic Spindle–associated Kinase 651
from multiple MTOCs, which coalesce to form a bipolar
spindle. Under these conditions, IAK1 is found to be as-
sociated with each MTOC as well as the mitotic spindle
(Fig. 8 A).
To further investigate the association of IAK1 with
MTOCs, we treated cells with taxol, which results in the
dispersal of pericentriolar material. The redistribution of
the pericentriolar material results in the formation of mul-
tiple miniasters in each mitotic cell. In NIH 3T3 cells
treated with taxol, the miniasters could be stained with the
anti–b-tubulin antiserum (Fig. 8 B). Each of these mini-
asters was also stained with varying intensity for IAK1. In
each mitotic cell, two prominent foci were strongly stained
with the IAK1 antiserum (Fig. 8 B). These asters may be
the only ones that contain centrioles and were formed be-
fore nuclear envelope breakdown. The remaining asters
likely represent ones that were nucleated by the dispersed
pericentriolar material. We did not observe IAK1 staining
in interphase cells treated with taxol, which is consistent
with our observations on IAK1 protein levels in these cells
(Fig. 8 B).
Expression of IAK1 Interferes with Ipl1p Function 
in Yeast
Given the sequence similarity between the mouse IAK1
and yeast Ipl1p protein kinases, we were interested in
knowing whether these two kinases might be functionally
related. In particular, we wanted to find out whether Ipl1p
function could be substituted by the expression of IAK1 in
yeast. For this purpose, we constructed plasmids express-
ing a wild-type or a mutant form (D287N) of IAK1 cDNA
under the control of the glucose-repressible and galactose-
inducible  GAL10 promoter (Johnson and Kolodner,
1991). These same cDNAs were tested for their kinase ac-
tivity by expressing flag-tagged versions in NIH 3T3 cells.
The flag-tagged proteins were immunoprecipitated using
an antiflag monoclonal antibody, and their kinase activity
was measured, using MBP as the exogenous substrate.
These data revealed that the D287N mutation in the metal
binding site reduced the kinase activity by 2.5-fold com-
pared to the wild-type kinase activity but did not totally
abolish kinase activity (Fig. 9). The yeast expression plas-
mids (IAK1WT and IAK1D287N) were then introduced into
wild-type and isogenic ipl1-4 temperature-sensitive mu-
tant cells (Francisco et al., 1994). Under inducing condi-
tions (on galactose medium), expression of IAK1 and the
mutant IAK1D287N form had no effect on the growth of the
wild-type yeast cells (Fig. 10). The wild-type construct also
failed to suppress the temperature-sensitive phenotype
caused by the recessive ipl-4 mutation. Thus, Ipl1p func-
tion cannot be substituted by the expression of IAK1. Sur-
prisingly, expression of IAK1 actually resulted in the le-
thality of ipl1-4 but not wild-type cells at the otherwise
permissive growth temperature of 308C (Fig. 10), even
scanning confocal microscope as described in Materials and
Methods. Cells are at the following stages of the cell cycle: inter-
phase (A), prophase (B), prometaphase (C), metaphase (D), late
anaphase (E), telophase (F), and cytokinesis (G). Bar, 5 mm.
Figure 7. Immunocytochemical localization of IAK1 during the
cell cycle. Dividing cultures of NIH 3T3 cells were fixed in ice-
cold methanol and then triple-stained with DAPI for DNA, with
an anti–b-tubulin monoclonal antibody for microtubules and with
an anti-IAK1 antiserum. The cells were visualized with a laserThe Journal of Cell Biology, Volume 138, 1997 652
fluorescence microscopy the effect of wild-type or mutant
IAK1 expression on the organization of chromosome mass
and microtubules in wild-type or ipl1-4 mutant cells. Our
results showed that the induction (by galactose) of wild-
type or mutant IAK1 expression for 10 h at 308C did not
result in specific cell cycle arrest of wild-type or ipl1-4 mu-
tant cells (data not shown). However, the organization of
chromosome mass and microtubules appeared abnormal
though similar amounts of IAK1 were produced in both
cell types (data not shown). Expression of a mutant form
of IAK1 (IAK1D287N) having reduced kinase activity also
resulted in lethality of ipl1-4 cells but not wild-type cells
(Fig. 11). Thus, expression of IAK1 appeared to interfere
with, rather than substitute for, Ipl1p function in yeast.
To determine how expression of IAK1 might result in
lethality in ipl1-4 mutant cells, we examined by immuno-
Figure 8. (A) Localization of IAK1 in nocodazole-treated cells. NIH 3T3 cells were treated with nocodazole (5 mg/ml) for 4 h, washed in
fresh medium, and then fixed in ice-cold methanol at various times after release from nocodazole block. Cells were stained with a mono-
clonal anti–b-tubulin antibody or an anti-IAK1 antiserum followed by the appropriate secondary antibodies and visualized by laser
scanning confocal microscopy as described in Materials and Methods. Shown are cells at time zero (0), 10 min after release from nocoda-
zole (10), 15 min after release (15), and 30 min after release (30). Bar, 5 mm. (B) Localization of IAK1 in taxol-treated cells. NIH 3T3
cells were treated with taxol (10 mM) for 5 h and then fixed in ice-cold methanol. Cells were stained with antibodies as above for b-tubu-
lin and IAK1. The two lower cells represent M-phase cells, while the upper cell is in interphase. Bar, 5 mm.Gopalan et al. A Novel Mammalian, Mitotic Spindle–associated Kinase 653
in a fraction of ipl1-4 mutant cells that expressed either
form of IAK1. This abnormal organization was best illus-
trated in large-budded yeast cells, which normally contain
more elaborate microtubule structures (Fig. 8). The most
common abnormality observed was the presence of ipl1-4
cells that had unseparated chromosome mass, a single
MTOC that is unduplicated or unseparated, and an appar-
ently monopolar spindle or no mitotic spindle (Fig. 11,
class e). This abnormal cytological phenotype has recently
been observed in some temperature-sensitive ipl1 mutant
cells incubated at their restrictive temperatures (Chan, C.,
unpublished results). Another common abnormality ob-
served was the presence of ipl1-4 cells that had unevenly
separated chromosome masses (Fig. 11, class h). A more
severe form of this phenotype has previously been re-
ported for ipl1-2 mutant cells incubated at elevated tem-
peratures (Francisco et al., 1994). Thus, expression of
wild-type or a mutant form of IAK1 in ipl1-4 mutant cells
at the otherwise permissive temperature of 308C resulted
in cytological phenotypes similar, though not identical, to
those exhibited by ipl1-2 mutant cells incubated at their
restrictive temperatures. This further suggests that expres-
sion of IAK1 interferes with Ipl1p function in yeast.
Discussion
Genetic and biochemical studies in yeast, flies, and toads
have identified some of the estimated 150–200 compo-
nents of the centrosome and mitotic spindle, but few such
proteins have been identified in mammalian cells (for re-
view see Kalt and Schliwa, 1993). Here we describe a novel
mammalian kinase, IAK1, whose expression is tightly regu-
lated, temporally and spatially, in the cell cycle. IAK1 has
a distinct expression pattern, being localized to the sepa-
rated, duplicated centrosomes and mitotic spindle of divid-
ing cells. In cells recovering from nocodazole treatment
and taxol-treated cells, IAK1 is associated with each
MTOC, suggesting that it may play a role in microtubule
formation and/or stabilization. Because of its inherent pro-
tein kinase activity and the timing of its expression and as-
sociation with the centrosome and spindle, IAK1 is clearly
a candidate regulator of phosphorylation changes on these
structures during mitosis. The localization of IAK1 that we
describe here is strikingly similar to another serine/threo-
nine kinase, the Polo-like kinase (Plk1) (Golsteyn et al.,
1995). Interestingly, Plk1 was detected in the centrosomes
of interphase cells and remained on those structures dur-
ing prophase and mitosis (Golsteyn et al., 1995). Plk1 and
Figure 9. The mutant IAK1D287N shows reduced kinase activity.
Cell extracts from NIH 3T3 cells transiently expressing the flag-
tagged IAK1 and IAK1D287N constructs were prepared, and the
wild-type and the mutant form of the kinase was selectively iso-
lated using the anti–flag M2 affinity gel as described in the Mate-
rials and Methods section. Mock-transfected cells were used as
the control. The affinity-purified wild-type and mutant form of
the IAK1 kinase was used for the in vitro kinase activity using
myelin basic protein as the substrate. The experiment was re-
peated three times, and the typical result from a single experi-
ment is presented here. The incorporation of [g-32P]ATP into
myelin basic protein was measured using a Molecular Dynamics
phosphoimager, and the result is presented in the form of a bar
diagram after background correction. The inset shows the autora-
diographic representation of the same result. Lane 1, control
mock-transfected cells; lane 2, IAK1; lane 3, IAK1D287N.
Figure 10. Expression of mouse IAK1
causes growth inhibition of ipl1 mutant
yeast cells. Suspension of yeast carrying
high copy number URA3-plasmid pAJ47
(control), IAKWT (containing wild-type
IAK1 cDNA under control of the GAL10
promoter), or IAKD287N (containing mu-
tant IAK1D287N cDNA under control of
the GAL10 promoter) were spotted on
supplemented minimal SD solid medium
(lacking uracil) that contained either glu-
cose or galactose as the sole carbon
source. These cells were allowed to grow
at the indicated temperatures for 3 d, ex-
cept that cells spotted on galactose me-
dium were allowed to grow at 268C for
5 d. The isogenic yeast strains used were
CCY98-3D-1 (wild-type IPL1) and CCY98-
3D-1-1 (mutant ipl1-4).The Journal of Cell Biology, Volume 138, 1997 654
IAK1 may interact to regulate each other’s function, but
we have been unable to demonstrate physical association
of these kinases in immunoprecipitation and Western blot
analyses (Chase, D., G. Gopalan, P.J. Donovan, and D.
Ferris, unpublished observations). Nevertheless, Plk1 and
IAK1 may be members of a common signal transduction
cascade. One striking difference between Plk1 and IAK1
is that Plk1, unlike IAK1, is detected in the cytoplasm of
interphase cells. Our Western blot data demonstrates that
IAK1 protein may be present in the cell in S-phase before
its immunocytochemical detection in the duplicated cen-
trosomes at the G2 phase of the cell cycle. This suggests ei-
ther that IAK1 may be present on the centrosome in S-phase,
but that the antigenic epitope recognized by the COOH-
terminal antiserum is masked, or that IAK1 may be present
in the centrosome or cytoplasm at levels undetectable with
our current reagents. Analysis of IAK1 protein levels in
subcellular fractions of S-phase cells should address this
question.
In cells treated with nocodazole, IAK1 remains associ-
ated with the centriole, suggesting that IAK1 association
with this structure is independent of the presence of poly-
merized microtubules. IAK1 localization in MTOCs and
spindles of cells recovering from nocodazole is consistent
with it playing some role in microtubule polymerization or
stabilization. A similar conclusion can be reached from the
localization of IAK1 to MTOCs in taxol-treated cells. One
potential role of IAK1 might be to stabilize microtubules,
which could lead to centrosome separation and microtu-
bule-mediated chromosome movements at mitosis. Alter-
natively, IAK1 might act on microtubule motor proteins
that have been implicated in the process of centrosome
separation and chromosome segregation (for review see
Walczak and Mitchison 1996). Indeed, Glover and col-
Figure 11. Expression of IAK1 causes microtubule defects in ipl1 mutant yeast cells. Isogenic wild-type IPL1 (CCY98-3D-1) and mu-
tant ipl1-4 (CCY98-3D-1-1) cells carrying the indicated plasmids (see Fig. 10 for description) were grown to early log phase at 308C in
supplemented minimal SD liquid medium (lacking uracil) that contained 2% raffinose as the sole carbon source (noninducing). At 0 h,
galactose was added to give a final concentration of 4% (inducing), and the cultures were incubated at 308C for another 10 h. At the
time indicated, cells were fixed with formaldehyde, and the distribution of chromosomal DNA and microtubules in these cells were ex-
amined by indirect immunofluorescence microscopy. For each sample, 200 large-budded cells were scored, and the percentage of cells
belonging to each cytological class is shown here. The classes represent: (a) cells with unseparated chromatin mass and a short to me-
dium bipolar mitotic spindle; (b) cells with chromatin mass that is not fully separated and with an elongated, bipolar mitotic spindle; (c)
cells with evenly separated chromatin masses and an elongated, bipolar mitotic spindle; (d) cells with evenly separated chromatin
masses and a partially disassembled mitotic spindle or no mitotic spindle; (e) cells with unseparated chromatin mass, a single undupli-
cated or unseparated MTOC (spindle pole body), and an apparently monopolar spindle or no mitotic spindle; (f) cells with unseparated
chromatin mass, a single unduplicated or unseparated MTOC, and no other microtubule structure; (g) cells with no MTOC or microtu-
bule structure; and (h) cells clearly with unevenly separated chromatin masses. The boxed region highlights the abnormal phenotypes in
ipl-4 yeast expressing the wild-type and IAK1D287N mammalian proteins.Gopalan et al. A Novel Mammalian, Mitotic Spindle–associated Kinase 655
leagues have suggested that the Drosophila aurora kinase
might act on a kinesin-related protein (Glover et al., 1995).
In this regard, it is apparent that the localization pattern of
IAK1 is very similar to that described for the kinesin-
related protein Eg5 in vertebrate cell lines (Houliston et
al., 1994). Whether IAK1 interacts with and phosphory-
lates Eg5 (or other kinesin-related proteins) is being ex-
amined. The ability of IAK1 to disrupt mitotic spindle ar-
chitecture and to affect the segregation of chromosome
mass in ts ipl1 mutants strongly suggests that it can interact
with a component of the yeast Ipl1 pathway or a closely re-
lated pathway. Thus, our current efforts to identify such a
protein may facilitate our further understanding of the
mode of action of IAK1.
What is the function of IAK1? The recent localization of
the Ipl1p protein kinase to the yeast mitotic spindle (Chan,
C., unpublished results) demonstrates that IAK1 is similar
to Ipl1p not only in sequence but also in subcellular local-
ization. Our data show that IAK1 cannot rescue the ipl1-4
mutant phenotype and therefore may not perform identi-
cal functions as Ipl1p. Nevertheless, the data presented
here also demonstrate that IAK1 exacerbates ipl1 mutant
phenotypes since it causes inviability of ipl1-4 mutant but
not wild-type cells (Fig. 7). These data suggest that IAK1
proteins act as dominant-negative proteins whose effect is
only seen when Ipl1p function is impaired. Similarly,
Nurse and colleagues showed that a kinase-dead Xenopus
CDK2 gene disrupted cell cycle progression in a ts cdc2
fission yeast mutant but not in wild-type cells (Paris et al.,
1994). This effect is most likely brought about by the abil-
ity of the expressed proteins to interfere with the activity
of the endogenous kinase by competing for interacting
proteins. Expression of other kinases (as well as several
other genes or mutations) in ts ipl1 mutants does not cause
lethality of the ts ipl1 mutant at the permissive tempera-
ture (Chan, C., unpublished observations). However, ex-
pression of the Drosophila aurora kinase, like IAK1,
caused lethality in ipl1-4 mutants but not in wild-type cells
at the permissive temperature (Chan, C., unpublished ob-
servations). This strongly suggests that the observed phe-
notype is specific and that IAK1 is not simply causing non-
specific lethality. Some of these cytological defects are also
observed in conditional ipl1 mutant cells incubated at their
restrictive temperatures and are also reminiscent of the ef-
fect of the aurora mutation in Drosophila. These observa-
tions strongly suggest that IAK1 interferes with the func-
tion of Ipl1p (or a parallel pathway), thus leading to
lethality in cells that already have compromised Ipl1p
function (due to the ipl1-4 mutation). IAK1 could interact
with Ipl1p itself, an upstream regulator of Ipl1p, a down-
stream effector (substrate) of Ipl1p, or a protein in a paral-
lel pathway. Disruption of IAK1 activity in mammalian
cells will probably address its role in centrosome and mi-
totic spindle function in mammalian cells.
The inability of IAK1 to rescue the ipl-4 mutation sug-
gests that IAK1 may not perform the identical functions as
Ipl1p. It is possible that an, as yet unidentified, relative of
IAK1, fulfills the Ipl1p function or that there is no single
functional homologue of Ipl1p in mammalian cells. Con-
ceivably the function(s) carried out by Ipl1p in yeast could
be carried out in mammalian cells by multiple kinases
which have evolved more complex or distinct forms of reg-
ulation. Interestingly, in addition to IAK1 we have identi-
fied another mammalian kinase, related to Ipl1 and au-
rora, which is not expressed in NIH 3T3 cells or most adult
tissues, but is expressed in germ cells (Gopalan, G., J. Cen-
tanni, and P.J. Donovan, manuscript in preparation). This
kinase, which shares 52% identity at the amino acid level
to IAK1, may play a similar role to IAK1 in meiotic germ
cells or may function during postmeiotic germ cell differ-
entiation. Another cell cycle–regulated kinase of unknown
function, STK1, has also recently been identified and
shows homology to IAK1 (see Fig. 2 B). The mouse ge-
nome therefore contains at least three members of this
subfamily and, based on chromosome localization studies,
may also contain another related gene (our own unpub-
lished observations). A Xenopus cDNA sequence (Eg2)
present in the GenBank database (accession number
Z17207)also shows a high degree of homology to IAK1,
STK1, Ipl1, and aurora (Fig. 2 B). As well as these other
genes, we have identified two related genes each in human
and worm (Gopalan, G., J. Schumacher, A. Golden, and
P.J. Donovan, unpublished observations). These data sug-
gest that aurora, IAK1, STK1, Eg2, and Ipl1 may be the
first members of an emerging subfamily of the serine/thre-
onine kinase superfamily that could play important roles
in centrosome and mitotic spindle function during mitosis.
Analysis of these related proteins in a variety of species
will probably allow a more complete understanding of the
function and mode of action of this protein family.
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